Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma

First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes from this viral infection due to the immunosuppression brought about by the un...

Full description

Bibliographic Details
Main Authors: Ipek Yonal-Hindilerden, Fehmi Hindilerden, Metban Mastanzade, Tarik Onur Tiryaki, Sevim Tasan-Yenigun, Yusuf Bilen, Selcuk Aksoz, Arif Atahan Cagatay, Meliha Nalcaci
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
coronavirus disease 2019
Hodgkin’s lymphoma
brentuximab
donor lymphocyte infusion
allogeneic stem cell
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.601709/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.601709/full

Similar Items